bioeconomy

On the heels of President Biden’s recent announcement of a Biotechnology and Biomanufacturing Initiative to boost the United States bioeconomy, the Congressional Research Service (CRS) has released The Bioeconomy: A Primer, which examines the future of the bioeconomy, explores the United States’ competitiveness in global bioeconomy efforts, and notes the current lack of federal coordination on building the bioeconomy. To address this lack of coordination, the report urges Congress to develop a more comprehensive national strategy for establishing the bioeconomy.   

On the 60th anniversary of President Kennedy's Moonshot Address, President Biden traveled to the John F. Kennedy Presidential Library and Museum to highlight progress toward his administration's Moonshot Program to combat cancer and expand the U.S. bioeconomy. This announcement included Biden's pick for the inaugural director of the Advanced Research Projects Agency for Health (ARPA-H) and the signing of an executive order to institute a National Biotechnology and Biomanufacturing Initiative.

A new Congressional Research Service (CRS) primer provides an overview of the bioeconomy and offers some potential federal policy considerations for strengthening the competitiveness of the U.S. in the global bioeconomy. Although it does not cover individual sectors that contribute to the bioeconomy, it gives a broad, macro-level perspective that may aid in a general understanding of that segment of the economy. The report offers an overview of past federal and legislative bioeconomy initiatives, but notes that it is not a comprehensive compilation of those activities.

A new Congressional Research Service (CRS) primer provides an overview of the bioeconomy and offers some potential federal policy considerations for strengthening the competitiveness of the U.S. in the global bioeconomy. Although it does not cover individual sectors that contribute to the bioeconomy, it gives a broad, macro-level perspective that may aid in a general understanding of that segment of the economy. The report offers an overview of past federal and legislative bioeconomy initiatives, but notes that it is not a comprehensive compilation of those activities.

The National Academies of Science, Engineering, and Medicine (NASEM) has set out to address the core risks that currently threaten the United States' bioeconomy with the release of their report Safeguarding the Bioeconomy. While the U.S. is currently leading the bio economic playing field, NASEM warns that the nation must be aware of the challenges from decentralized leadership, inadequate talent development, cybersecurity vulnerabilities, stagnant investment in fundamental research, and international competition if it hopes to continue its success. The report recommends steps the U.S. could take to mitigate these risks and sustain a strong bioeconomy, including forming a coordinating body within the Executive Office of the President to ensure coordination across the science, economic, regulatory, and security agencies.